Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Payables: 2014-2024

Historic Payables for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $208.7 million.

  • Surgery Partners' Payables rose 222.48% to $174.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.6 million, marking a year-over-year increase of 222.48%. This contributed to the annual value of $208.7 million for FY2024, which is 2147.85% up from last year.
  • Per Surgery Partners' latest filing, its Payables stood at $208.7 million for FY2024, which was up 2147.85% from $171.8 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Payables ranged from a high of $208.7 million in FY2024 and a low of $100.2 million during FY2020
  • Its 5-year average for Payables is $151.4 million, with a median of $151.6 million in 2022.
  • As far as peak fluctuations go, Surgery Partners' Payables skyrocketed by 361.94% in 2020, and later surged by 2465.07% in 2021.
  • Annual analysis of 5 years shows Surgery Partners' Payables stood at $100.2 million in 2020, then rose by 24.65% to $124.9 million in 2021, then rose by 21.38% to $151.6 million in 2022, then rose by 13.32% to $171.8 million in 2023, then rose by 21.48% to $208.7 million in 2024.
  • Its Payables stands at $208.7 million for FY2024, versus $171.8 million for FY2023 and $151.6 million for FY2022.